Indivior Share Price | |
---|---|
Price | 1,514.00 |
Bid | 1,518.00 |
Ask | 1,525.00 |
Change | -6.00 (-0.39%) |
Volume | 518,018 |
Open | 1,540.00 |
High | 1,540.00 |
Low | 1,496.00 |
Prev. Close | 1,520.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 135.51m |
Market Capitalisation | £2.05b |
Market Size | 1,500 |
52 Week High | 1,927.00 |
52 Week High Date | 27-Jul-2023 |
52 Week Low | 1,128.00 |
52 Week Low Date | 19-Dec-2023 |
# Trades | 1,336 |
---|---|
Vol. Sold | 234,679 |
Sold Value | £3.56m |
Vol. Bought | 55,101 |
Bought Value | £836.67k |
PE Ratio | 1,927.61635 |
Earnings | 0.785426 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-Apr-24 | 18:09:01 | 1,523.836 | 4,079 | Unknown* | 1,518.00 | 1,525.00 | 62.16k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:07:44 | 1,522.904 | 820 | Unknown* | 1,518.00 | 1,525.00 | 12.49k | O Ordinary Was reported as OTC |
24-Apr-24 | 18:07:44 | 1,519.463 | 1,954 | Unknown* | 1,518.00 | 1,525.00 | 29.69k | O Ordinary Was reported as OTC |
24-Apr-24 | 17:54:49 | 1,514.00 | 1,622 | Unknown* | 1,518.00 | 1,525.00 | 24.56k | O Ordinary Was reported as OTC |
24-Apr-24 | 17:46:23 | 1,518.27 | 16,845 | Unknown* | 1,518.00 | 1,525.00 | 255.75k | O Ordinary Was reported as OTC |
24-Apr-24 | 17:44:33 | 1,513.151 | 90 | Unknown* | 1,518.00 | 1,525.00 | 1,362 | O Ordinary Was reported as OTC |
24-Apr-24 | 17:44:33 | 1,511.601 | 958 | Unknown* | 1,518.00 | 1,525.00 | 14.48k | O Ordinary Was reported as OTC |
24-Apr-24 | 17:44:33 | 1,512.151 | 145 | Unknown* | 1,518.00 | 1,525.00 | 2,193 | O Ordinary Was reported as OTC |
24-Apr-24 | 17:39:19 | 1,506.852 | 108 | Unknown* | 1,518.00 | 1,525.00 | 1,627 | O Ordinary Was reported as OTC |
24-Apr-24 | 17:38:10 | 1,506.80 | 10 | Unknown* | 1,518.00 | 1,525.00 | 150.68 | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
18-Mar-24 | 15-Mar-24 | Transfer From | Ryan Preblick held the position of CFO & Executive Director at the time of this trade.Ryan Preblick | 0.00 | 3,920 | 229,089 | |
18-Mar-24 | 18-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,617.00 | GBX | 10,549 | 335,935 |
18-Mar-24 | 15-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,644.00 | GBX | 15,444 | 335,935 |
18-Mar-24 | 14-Mar-24 | Sell | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 1,630.00 | GBX | 91,204 | 335,935 |
18-Mar-24 | 15-Mar-24 | Exercise of Option | Mark Crossley held the position of CEO at the time of this trade.Mark Crossley | 555.00 | GBX | 15,444 | 335,935 |
Indivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.